Compare WTRG & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WTRG | RVTY |
|---|---|---|
| Founded | 1901 | 1937 |
| Country | United States | United States |
| Employees | 1615 | N/A |
| Industry | Water Supply | Biotechnology: Laboratory Analytical Instruments |
| Sector | Utilities | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 11.8B |
| IPO Year | 1994 | 1994 |
| Metric | WTRG | RVTY |
|---|---|---|
| Price | $38.07 | $86.70 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 16 |
| Target Price | $43.50 | ★ $109.67 |
| AVG Volume (30 Days) | ★ 1.9M | 934.4K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.47% | 0.34% |
| EPS Growth | ★ 1.38 | N/A |
| EPS | ★ 2.20 | 2.07 |
| Revenue | $2,474,615,000.00 | ★ $3,311,822,000.00 |
| Revenue This Year | $5.07 | $6.37 |
| Revenue Next Year | $7.31 | $5.10 |
| P/E Ratio | ★ $17.40 | $41.98 |
| Revenue Growth | ★ 18.62 | N/A |
| 52 Week Low | $36.32 | $81.22 |
| 52 Week High | $42.37 | $118.30 |
| Indicator | WTRG | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 38.88 | 45.39 |
| Support Level | $37.29 | $83.22 |
| Resistance Level | $40.01 | $88.60 |
| Average True Range (ATR) | 1.00 | 3.35 |
| MACD | -0.13 | -0.53 |
| Stochastic Oscillator | 17.05 | 35.52 |
Essential Utilities is a Pennsylvania-based holding company for US water, wastewater, and natural gas distribution utilities. The company's water business serves 3 million people in eight states. Its largest service territory is in Pennsylvania, primarily suburban Philadelphia. Its Peoples subsidiary serves more than 740,000 gas distribution customers in Pennsylvania and Kentucky. It completed the sale of its West Virginia gas utility and the bulk of its nonregulated assets in 2024. Essential shareholders would own a 31% stake in American Water Works if the proposed all-stock merger closes in 2027.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.